CDT Equity Inc. (CDT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $407,550
Last updated: Nov 17, 2026 at 11:04 AM ET
CDT Equity Inc. (CDT) Competitors
The companies most similar to CDT Equity are Karyopharm Therapeutics (KPTI), CERo Therapeutics Holdings, Inc. Common Stock (CERO) and Onconetix (ONCO). By market cap, CDT Equity ranks 11th of the 13 companies on this page; Onconetix (ONCO) is the largest at $2.15M.
Peer Comparison
CDT's revenue growth of 0.0% is above the peer median of -6.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| CDT Equity (CDT) | $407550 | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Karyopharm Therapeutics Inc (KPTI) | $394660 | N/A | N/A | -153.3% | 64.5% | -11.9% | 0.00% |
| CERo Therapeutics Holdings, Inc. Common Stock (CERO) | $358150 | N/A | N/A | 0.0% | 68.9% | 0.0% | 0.00% |
| Onconetix Inc (ONCO) | $2.15M | N/A | 1.0x | 0.0% | N/A | -83.9% | 0.00% |
| Matinas BioPharma Holdings Inc (MTNB) | $881570 | 0.9x | N/A | 0.0% | -187.9% | -100.0% | 0.00% |
| Scisparc Ltd (SPRC) | $869840 | N/A | N/A | 0.0% | N/A | -38.4% | 0.00% |
| Scinai Immunotherapeutics Ltd (SCNI) | $1.05M | N/A | N/A | -80.1% | N/A | 572.0% | 0.00% |
| HCW Biologics Inc (HCWB) | $1.73M | N/A | 0.2x | -83.1% | -51.6% | 1970.0% | 0.00% |
| Kairos Pharma, Ltd. (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| GeoVax Labs Inc (GOVX) | $928290 | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Virax Biolabs Group Limited Ordinary Shares (VRAX) | $823940 | N/A | 14.3x | 0.0% | N/A | 685.0% | 0.00% |
| Oragenics Inc (OGEN) | $906900 | N/A | N/A | 0.0% | -656.1% | -91.3% | 0.00% |
| Silexion Therapeutics Corp (SLXN) | $1.29M | N/A | 5.9x | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $917595 | 0.9x | 3.5x | 0.0% | -51.6% | -6.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to CDT Equity, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Karyopharm Therapeutics Inc (KPTI) | Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery... | KPTI competitors |
| CERo Therapeutics Holdings, Inc. Common Stock (CERO) | CERo Therapeutics Holdings, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for patients with serious diseases. | |
| Onconetix Inc (ONCO) | Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. | ONCO competitors |
| Matinas BioPharma Holdings Inc (MTNB) | Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products. | MTNB competitors |
| Scisparc Ltd (SPRC) | SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. | |
| Scinai Immunotherapeutics Ltd (SCNI) | Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune... | SCNI competitors |
| HCW Biologics Inc (HCWB) | HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues... | HCWB competitors |
| Kairos Pharma, Ltd. (KAPA) | Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. | KAPA competitors |
| GeoVax Labs Inc (GOVX) | GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified... | GOVX competitors |
| Virax Biolabs Group Limited Ordinary Shares (VRAX) | Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE... | |
| Oragenics Inc (OGEN) | Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida. | OGEN competitors |
| Silexion Therapeutics Corp (SLXN) | Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine... | SLXN competitors |
Frequently Asked Questions About CDT
Who are CDT Equity's main competitors?
The companies most similar to CDT Equity include Karyopharm Therapeutics (KPTI), CERo Therapeutics Holdings, Inc. Common Stock (CERO), Onconetix (ONCO), Matinas BioPharma Holdings (MTNB) and Scisparc (SPRC), listed from the closest match.
Who is CDT Equity's biggest competitor?
Onconetix (ONCO) is the largest of the similar companies at $2.15M; Karyopharm Therapeutics (KPTI) is the closest match by business profile, size, sector and industry.
How does CDT stock compare with its competitors?
CDT's net margin is 0.0% against a peer median of 0.0%.
Which of CDT Equity's competitors pays a higher dividend?
CDT Equity pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is CDT Equity bigger than its competitors?
No. CDT Equity is 11th by market cap among the 13 companies on this page; the largest is Onconetix (ONCO) at $2.15M.
CDT pages: Overview, Financials, Competitors